The Connection Between CLL and Limb Neuropathy

Chronic lymphocytic leukemia is a usually slow-growing cancer involving abnormal lymphocytes, most often B lymphocytes. It primarily affects the blood, bone marrow, lymph nodes, and immune system. Common CLL symptoms include fatigue, enlarged lymph nodes, frequent infections, night sweats, unexplained weight loss, easy bruising, and abdominal fullness caused by an enlarged spleen. Numb toes do not normally appear near the top of that list.

Even so, researchers and clinicians have documented peripheral neuropathy in a small percentage of people with CLL. In one single-center study of 816 patients, 19 peopleabout 2.2%were diagnosed with peripheral neuropathy. Because this was one observational population, the number should not be treated as a universal rate. It does, however, support the practical conclusion that neuropathy is possible but uncommon in CLL.

The most important question is therefore not simply, “Can CLL cause neuropathy?” It is, “What is causing neuropathy in this particular person with CLL?” That question requires some detective workand preferably more sophisticated detective work than blaming every unusual sensation on the cancer.

What Is Limb Neuropathy?

Peripheral neuropathy develops when nerves outside the brain and spinal cord become damaged or dysfunctional. These peripheral nerves connect the central nervous system to the arms, hands, legs, feet, muscles, skin, and internal organs.

Limb neuropathy commonly starts in the toes or feet because the longest nerves are often affected first. Symptoms may gradually move upward and later involve the fingers or hands, creating the classic “stocking-and-glove” pattern. Depending on the nerves involved, symptoms can be sensory, motor, autonomic, or a mixture of all three.

Sensory symptoms

• Tingling or pins-and-needles sensations
• Burning, stabbing, electric, or shooting pain
• Numbness or reduced ability to feel touch
• Unusual sensitivity to light contact
• Difficulty detecting heat, cold, or injuries

Motor symptoms

• Leg, ankle, foot, hand, or arm weakness
• Muscle cramps or twitching
• Difficulty climbing stairs or opening containers
• Foot drop or toes dragging during walking
• Poor balance, stumbling, or unexplained falls

Autonomic symptoms

If autonomic nerves are affected, a person may experience dizziness when standing, abnormal sweating, digestive changes, urinary difficulties, or sexual dysfunction. These symptoms are less obviously “neurological,” which is one reason neuropathy occasionally arrives at the diagnostic party wearing a fake mustache.

How CLL May Be Connected to Peripheral Neuropathy

1. Neuropathy from cancer treatment

Some cancer treatments can damage peripheral nerves. The risk depends on the specific medication, dose, treatment duration, previous therapies, and the patient’s existing health conditions. Symptoms may begin during treatment, shortly afterward, or occasionally months later. Treatment-related neuropathy may improve after therapy ends, but recovery can be slow, incomplete, or unpredictable.

Modern CLL care increasingly relies on targeted drugs, including BTK inhibitors and BCL-2 inhibitors, sometimes combined with monoclonal antibodies. These medications have different side-effect profiles from older chemotherapy regimens, and peripheral neuropathy is not automatically expected with every CLL treatment. A medication review is therefore essential rather than assuming that all “cancer drugs” affect nerves in the same way.

Vincristine is a well-known example of a nerve-toxic chemotherapy drug. It is not a routine component of most contemporary frontline CLL treatment, but it can be included in lymphoma-directed combinations such as R-CHOP when CLL transforms into a more aggressive lymphoma known as Richter transformation. That clinical context matters enormously.

Never stop, reduce, or skip a CLL medication because of tingling or numbness without speaking to the prescribing oncology team. The solution may involve monitoring, adjusting the dose, changing the schedule, switching therapies, or treating a completely unrelated condition.

2. Immune-mediated nerve damage

CLL disrupts immune regulation. Although immune complications most famously involve blood cells, abnormal immune activity can occasionally target peripheral nerves or the protective myelin coating surrounding them.

Some patients develop inflammatory neuropathies resembling chronic inflammatory demyelinating polyneuropathy, or CIDP. CIDP often causes gradually worsening weakness, reduced reflexes, numbness, and difficulty walking. Other cases may involve abnormal antibodies or monoclonal proteins that react with nerve structures. These conditions are uncommon, and their diagnosis generally requires neurological testing rather than guesswork based on symptoms alone.

3. Direct infiltration of nerves

In extremely rare situations, malignant lymphocytes may infiltrate peripheral nerves, nerve roots, or nerve plexuses. This process is sometimes called neurolymphomatosis. It may produce severe pain, rapidly progressive weakness, or an asymmetric pattern affecting one limb or nerve more than another.

Direct infiltration is far less common than diabetes, medication toxicity, or mechanical nerve compression. Nevertheless, doctors may consider it when symptoms are unusually painful, focal, progressive, or accompanied by signs that CLL has become more active. Reviews of neurological complications in lymphoproliferative diseases identify direct infiltration, chemotherapy toxicity, infections, immune mechanisms, metabolic disorders, and nutritional deficiencies as distinct possible pathways to nerve injury.

4. Infections associated with immune suppression

CLL and some of its treatments weaken immune defenses, increasing susceptibility to infections. Certain infections can injure nerves directly or trigger inflammation around them. Shingles, for example, may produce persistent nerve pain after the rash resolves. Other viral or bacterial infections can occasionally cause more widespread neuropathy.

New burning pain followed by a stripe of blisters should be reported promptly. Antiviral treatment is generally most useful when started early, particularly in someone whose immune system is compromised.

5. Conditions unrelated to CLL

A person can have CLL and an entirely separate cause of neuropathy. In fact, this is often the most likely scenario. Common possibilities include:

• Diabetes or prediabetes
• Vitamin B12, folate, or other nutritional deficiencies
• Thyroid disease
• Kidney or liver dysfunction
• Heavy alcohol use
• Previous chemotherapy for another cancer
• Carpal tunnel syndrome or another trapped nerve
• A herniated disk, spinal stenosis, or nerve-root compression
• Autoimmune disease
• Certain antibiotics and other noncancer medications

Age also matters. Because CLL is most often diagnosed in older adults, many patients already have one or more neuropathy risk factors before leukemia enters the picture. Two conditions can coexist without one causing the othera medical concept known informally as “the body is allowed to be inconvenient in more than one way.”

How Doctors Determine the Cause

Evaluation usually begins with a detailed timeline. The clinician will want to know when symptoms started, whether they appeared before or after treatment, how quickly they progressed, and whether both sides are affected equally.

Medical and neurological examination

A physical examination may assess strength, reflexes, balance, coordination, walking pattern, vibration sensation, temperature perception, and sensitivity to touch. The distribution of symptoms can provide useful clues. Symmetrical numbness beginning in both feet suggests a different process from sudden weakness affecting one foot.

Laboratory testing

Depending on the clinical picture, blood tests may include a complete blood count, metabolic panel, fasting glucose or A1C, vitamin B12, folate, thyroid tests, kidney and liver markers, and tests for abnormal antibodies or proteins. Infection testing may be appropriate when the history suggests a viral or bacterial cause.

Nerve conduction studies and electromyography

Nerve conduction studies measure how effectively electrical signals travel through peripheral nerves. Electromyography, commonly called EMG, evaluates electrical activity in muscles. Together, these tests can help distinguish damage to nerve fibers from damage to myelin, nerve roots, muscles, or the neuromuscular junction.

Imaging and specialized tests

MRI may be ordered when symptoms suggest spinal compression, nerve-root disease, or a focal lesion. In selected cases, doctors may consider a lumbar puncture, skin biopsy, nerve biopsy, or imaging designed to look for infiltration around nerves. These tests are not routine for every tingling toe; they are reserved for cases in which the results could meaningfully change treatment.

Because the possible causes cross medical specialties, collaboration between a hematologist-oncologist and a neurologist is often valuable.

How Limb Neuropathy Is Treated in Someone With CLL

Treatment begins with the cause. There is no single universal “CLL neuropathy medicine,” because nerve symptoms related to diabetes require a different strategy from immune-mediated neuropathy, shingles, spinal compression, or drug toxicity.

Addressing the underlying problem

• A treatment-related case may require an oncology-supervised dose adjustment or medication change.
• A vitamin deficiency may require replacement therapy.
• Diabetic neuropathy requires blood sugar management.
• An infection may require antiviral or antimicrobial medication.
• An inflammatory neuropathy may be treated with therapies such as intravenous immunoglobulin, corticosteroids, or plasma exchange in carefully selected patients.
• A compressed nerve may require physical therapy, bracing, injections, or surgical evaluation.

Controlling nerve pain

Doctors may use medications such as duloxetine, gabapentin, pregabalin, or certain low-dose antidepressants for neuropathic pain, depending on the cause and the patient’s other medications. Topical lidocaine or capsaicin may help localized symptoms. Medication selection must account for sedation, dizziness, kidney function, fall risk, bleeding risk, and drug interactions.

Evidence for supplements is inconsistent, and some products can interfere with cancer medications or affect blood sugar and bleeding. “Natural” does not mean “invisible to your pharmacist.” Discuss vitamins, herbal remedies, and high-dose antioxidants with the oncology team before using them.

Protecting mobility and independence

Physical therapy can strengthen muscles, improve walking mechanics, and reduce fall risk. Occupational therapy may help with hand weakness and daily tasks. A cane, walker, ankle-foot brace, shower rail, or night-light is not an admission of defeat; it is equipment doing its job.

People with reduced foot sensation should check their feet daily for cuts, blisters, pressure areas, or burns. Supportive shoes, clear walking paths, nonslip bathroom surfaces, and careful water-temperature checks can prevent injuries that might otherwise go unnoticed.

When Neuropathy Symptoms Require Urgent Care

Contact the cancer care team promptly for new or worsening numbness, burning, weakness, balance problems, or difficulty using the hands. Seek urgent or emergency care for:

• Sudden weakness or numbness on one side of the body
• Facial drooping, confusion, or difficulty speaking
• Rapidly ascending weakness that begins in the legs
• Difficulty breathing, swallowing, or holding up the head
• Loss of bladder or bowel control with back pain or leg weakness
• Inability to walk or repeated falls
• Severe limb pain with swelling, color changes, or loss of circulation
• A painful blistering rash, especially during immune-suppressing treatment

These symptoms may reflect a stroke, spinal emergency, serious infection, rapidly progressive inflammatory neuropathy, blood clot, or another condition requiring immediate assessment.

Experiences People May Have With CLL and Limb Neuropathy

The following examples are realistic composite scenarios created for education. They are not quotations from individual patients and should not be interpreted as personal medical advice.

The sensation of wearing an invisible sock

One common experience begins quietly. A person notices that the toes on both feet feel slightly padded, as though a thick sock remained in place after the real socks came off. There may be no pain, just an odd reduction in sensation. Over several months, the numbness rises toward the ankles, and walking in the dark becomes less comfortable because the feet are providing less information about the floor.

Someone with CLL may naturally assume that the leukemia is progressing. Testing, however, might reveal previously unrecognized diabetes or vitamin B12 deficiency. In this situation, the neuropathy is real and deserves treatment, but it is not evidence that the CLL has suddenly become aggressive.

Symptoms that begin after a treatment change

Another person may develop burning or tingling several weeks after starting or changing cancer treatment. The timing raises suspicion that medication is contributing, but timing alone does not prove causation. The oncology team reviews the complete drug list, including antibiotics, over-the-counter products, and medications prescribed by other doctors.

The patient may be asked to describe whether the discomfort is constant, whether it affects both sides, and whether weakness accompanies the tingling. Keeping a short symptom diary can be surprisingly useful. A note such as “burning began ten days after cycle two and is worse at night” gives the care team more to work with than “my feet are being weird again.”

One weak foot rather than two numb feet

A person who suddenly begins catching one toe on the carpet has a different pattern. One-sided foot drop may reflect compression of the peroneal nerve near the knee, a problem in the lower spine, or another focal neurological disorder. It does not resemble the usual symmetrical pattern of metabolic polyneuropathy.

This distinction affects testing. The clinician may prioritize imaging and nerve conduction studies rather than ordering only nutritional blood tests. A brace may stabilize the ankle while the underlying cause is investigated and treated.

The practical burden is larger than the pain score

Neuropathy does not need to produce spectacular pain to disrupt daily life. Numb fingertips can make buttons, coins, phone screens, or medication bottles unexpectedly frustrating. Reduced foot sensation can turn an ordinary shower into a burn risk and a dim hallway into an obstacle course.

Many people benefit from small adaptations: shoes with stable soles, motion-activated lights, handrails, a shower seat, pill organizers that are easy to open, and extra time for tasks requiring fine motor control. These adjustments may sound modest, but they preserve independence and reduce the exhausting need to concentrate on every step.

The emotional experience of diagnostic uncertainty

Perhaps the hardest part is not knowing what the symptom means. For someone living with CLL, every new ache can feel like a message written in an alarming secret code. Neuropathy evaluation helps replace that uncertainty with a structured plan: identify the pattern, check common causes, review treatment, test nerve function when needed, and escalate the investigation if symptoms are unusual.

The eventual answer may involve CLL, its treatment, another illness, or several overlapping factors. Regardless of the cause, reporting symptoms early gives clinicians the best opportunity to prevent additional nerve damage, improve safety, and control discomfort.

Conclusion

Limb neuropathy can be associated with chronic lymphocytic leukemia, but it is an uncommon complication and is not considered a classic sign of CLL progression. Possible connections include treatment toxicity, immune-mediated nerve injury, infection, abnormal antibodies, andvery rarelydirect infiltration of nerves.

More common explanations such as diabetes, vitamin deficiency, medication effects, trapped nerves, and spinal disease must also be investigated. The pattern, timing, and speed of progression often provide the first clues. New symptoms should be discussed with the oncology team, especially when they involve weakness, falls, severe pain, or rapidly changing function.

Note: This article provides general educational information and is not a substitute for diagnosis or treatment from a qualified healthcare professional. Do not change CLL medication or begin supplements for neuropathy without consulting the prescribing medical team.